Izquierdo-Garcia D, Desogere P, Philip A, Sosnovik D, Catana C, Caravan P
Mol Imaging Biol. 2024; 27(1):99-108.
PMID: 39633070
DOI: 10.1007/s11307-024-01973-3.
Torralba-Maldonado D, Marlin A, Lucio-Martinez F, Freire-Garcia A, Whetter J, Brandariz I
Inorg Chem. 2024; 63(46):22297-22307.
PMID: 39508185
PMC: 11577316.
DOI: 10.1021/acs.inorgchem.4c04050.
Basaco Bernabeu T, Mansi R, Del Pozzo L, Gaonkar R, McDougall L, Johayem A
Front Nucl Med. 2024; 4:1481343.
PMID: 39464654
PMC: 11503464.
DOI: 10.3389/fnume.2024.1481343.
Chuki E, Anaraki K, Jha A, Patel M, Ling A, Pacak K
JCEM Case Rep. 2024; 2(11):luae181.
PMID: 39430735
PMC: 11487291.
DOI: 10.1210/jcemcr/luae181.
Badier L, Quelven I
Pharmaceutics. 2024; 16(7).
PMID: 39065579
PMC: 11279968.
DOI: 10.3390/pharmaceutics16070882.
Approach to the Patient: Concept and Application of Targeted Radiotherapy in the Paraganglioma Patient.
Pacak K, Taieb D, Lin F, Jha A
J Clin Endocrinol Metab. 2024; 109(9):2366-2388.
PMID: 38652045
PMC: 11319006.
DOI: 10.1210/clinem/dgae252.
Diagnostic performance of [Ga]DOTATATE PET/CT, [F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma.
Jha A, Patel M, Ling A, Shah R, Chen C, Millo C
Eur Radiol. 2024; 34(10):6488-6498.
PMID: 38625612
PMC: 11399174.
DOI: 10.1007/s00330-024-10652-4.
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments.
Richter S, Steenblock C, Fischer A, Lemm S, Ziegler C, Bechmann N
Theranostics. 2024; 14(1):17-32.
PMID: 38164150
PMC: 10750207.
DOI: 10.7150/thno.87345.
Cu-Labeled Radiotracers: Alternative or Choice?.
Fani M, Nicolas G
J Nucl Med. 2023; 64(12):1855-1857.
PMID: 37884329
PMC: 10690116.
DOI: 10.2967/jnumed.123.266171.
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.
Echavidre W, Fagret D, Faraggi M, Picco V, Montemagno C
Cancers (Basel). 2023; 15(19).
PMID: 37835533
PMC: 10572076.
DOI: 10.3390/cancers15194839.
Widespread micronodular hepatic metastases of neuroendocrine tumor detected by [Ga]DOTATATE PET/CT.
DSouza J, OBrien S, Yang Z, El Jack A, Pantel A
Radiol Case Rep. 2022; 18(2):481-485.
PMID: 36439918
PMC: 9691422.
DOI: 10.1016/j.radcr.2022.10.059.
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review.
Poletto G, Cecchin D, Sperti S, Filippi L, Realdon N, Evangelista L
Curr Issues Mol Biol. 2022; 44(11):5516-5530.
PMID: 36354685
PMC: 9689511.
DOI: 10.3390/cimb44110373.
New Biology of Pheochromocytoma and Paraganglioma.
Pacak K
Endocr Pract. 2022; 28(12):1253-1269.
PMID: 36150627
PMC: 9982632.
DOI: 10.1016/j.eprac.2022.09.003.
